Protagonist Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PTGX and other ETFs, options, and stocks.About PTGX
Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline includes PTG-300, PTG-200, and PN-943.
CEODinesh V. Patel
CEODinesh V. Patel
Employees126
Employees126
HeadquartersNewark, California
HeadquartersNewark, California
Founded2006
Founded2006
Employees126
Employees126
PTGX Key Statistics
Market cap4.94B
Market cap4.94B
Price-Earnings ratio109.29
Price-Earnings ratio109.29
Dividend yield—
Dividend yield—
Average volume877.79K
Average volume877.79K
High today$79.56
High today$79.56
Low today$77.00
Low today$77.00
Open price$77.07
Open price$77.07
Volume317.78K
Volume317.78K
52 Week high$93.25
52 Week high$93.25
52 Week low$33.31
52 Week low$33.31
Stock Snapshot
The current Protagonist Therapeutics(PTGX) stock price is $79.33, with a market capitalization of 4.94B. The stock trades at a price-to-earnings (P/E) ratio of 109.29.
On 2025-11-06, Protagonist Therapeutics(PTGX) stock traded between a low of $77.00 and a high of $79.56. Shares are currently priced at $79.33, which is +3.0% above the low and -0.3% below the high.
Protagonist Therapeutics(PTGX) shares are trading with a volume of 317.78K, against a daily average of 877.79K.
During the past year, Protagonist Therapeutics(PTGX) stock moved between $33.31 at its lowest and $93.25 at its peak.
During the past year, Protagonist Therapeutics(PTGX) stock moved between $33.31 at its lowest and $93.25 at its peak.
Analyst ratings
93%
of 14 ratingsBuy
92.9%
Hold
7.1%
Sell
0%
People also own
Based on the portfolios of people who own PTGX. This list is generated using Robinhood data, and it’s not a recommendation.